Skip to Content

Join the 'Stilphostrol' group to help and get support from people like you.

Stilphostrol News

Banned Pregnancy Drug, Diethylstilbestrol, Linked to ADHD Generations Later

Posted 1 day 14 hours ago by Drugs.com

MONDAY, May 21, 2018 – A pregnancy drug that has been banned for decades may increase the risk for attention-deficit/hyperactivity disorder (ADHD) generations later, new research suggests. The study found that the grandchildren of women who took a synthetic estrogen, diethylstilbestrol (also known as DES), to prevent pregnancy complications between 1938 and 1971 are more likely to have the ...

Harms of Banned Pregnancy Drug, DES, Linger for Decades in Daughters

Posted 3 May 2018 by Drugs.com

WEDNESDAY, May 2, 2018 – Women who were exposed to synthetic estrogen (DES) in the womb and developed a rare form of cancer of the vagina and cervix continue to face an increased risk of death, a new study shows. DES was once commonly given to pregnant women because it was believed it could prevent miscarriage and preterm birth. However, the U.S. Food and Drug Administration issued a warning in ...

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps ...

Breast Cancer More Lethal for Blacks Than Whites

Posted 16 Oct 2017 by Drugs.com

MONDAY, Oct. 16, 2017 – Differences in insurance are a major reason why black women are more likely to die of breast cancer than white women in the United States, a new study contends. "We found that differences in insurance explained one-third of the total excess risk of death in non-elderly black women compared to white women diagnosed with early stage breast cancer, while differences in tumor ...

Could Hormone Supplements for Menopause Make a Comeback?

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – The door may be opening again for menopausal women suffering from hot flashes and night sweats to receive some relief from a source once thought too dangerous to consider, researchers say. Hormone replacement therapy to treat symptoms of menopause does not increase a woman's risk of early death – either overall or specifically from cancer or heart disease, according to ...

Alternative Medicine Alone as Cancer Treatment Linked to Lowered Survival

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – People who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, researchers report. "We now have evidence to suggest that using alternative medicine in place of proven cancer therapies results in worse survival," said study lead author Dr. Skyler Johnson from Yale School of Medicine and Yale Cancer Center. ...

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris ...

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In ...

Most Breast Cancer Patients Have Help Choosing Treatments

Posted 10 Jul 2017 by Drugs.com

MONDAY, July 10, 2017 – Most women who've been diagnosed with breast cancer don't go it alone. Many breast cancer patients depend on family and friends to help them make treatment decisions, get to doctor appointments and seek out other resources. A new study finds half of women rely on three or more people to help them through it. "People just diagnosed with cancer are often scared and ...

FDA Widens Access to 'Cooling Cap' to Stop Hair Loss in Cancer Patients

Posted 5 Jul 2017 by Drugs.com

WEDNESDAY, July 5, 2017 – More cancer patients may be able to ward off hair loss during chemotherapy treatment. A cooling cap approved in 2015 for use in breast cancer patients has won expanded approval from the U.S. Food and Drug Administration. The DigniCap Cooling System can now be used for patients with solid tumors, the FDA announced. The computer-controlled cap contains liquid that ...

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, ...

Hormone Replacement Therapy Tied to Hearing Loss

Posted 12 May 2017 by Drugs.com

FRIDAY, May 12, 2017 – Hearing loss has been linked to several factors associated with menopause, a new study says. One factor is your age at menopause. An older age is tied to a higher risk of hearing troubles. And, a second factor is the use of oral hormone therapy to ease some of the symptoms of menopause. The researchers also found that the longer a woman used hormone therapy, the greater ...

HRT Won't Lower Women's Alzheimer's Risk, Study Finds

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – Women who use hormone therapy after menopause may not have a lower risk of developing Alzheimer's, a new study suggests. However, there was some evidence that long-term use – over a decade – might be tied to a lower risk of the memory-robbing brain disease. But the results were far from definitive, the researchers added. The study is the latest to delve into the ...

Fat Near the Heart a Hazard for Postmenopausal Women

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – When a certain type of fat collects around the heart, it may be a sign of developing heart disease in postmenopausal women, a new study suggests. As estrogen levels fall during menopause, deposits of "paracardial" fat increase, the researchers found. This may cause more calcium build-up in the heart's arteries, an early sign of heart disease. Paracardial fat sits in ...

'Chemo Brain' Lasts for Months in Many Breast Cancer Survivors

Posted 11 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 11, 2017 – "Chemo brain" – the mental fog common after breast cancer treatment – can persist for six months, new research shows. The finding comes from one of the largest studies to date to look at chemotherapy-related thinking problems that plague many women treated for breast cancer. Those problems can include memory lapses, attention issues and difficulty processing ...

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Primary Ovarian Failure, Prostate Cancer